$TDOC Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.15 up 46.43% YoY
• Reported revenue of $605.1M down -3.41% YoY
• Teladoc Health expects full-year 2026 revenue of $2.4B, adjusted EBITDA of $277M, net loss per share of -$0.95, and free cash flow of $135M.